Elevated serum levels of interleukin-15 and interleukin-16 in preeclampsia

Journal of Reproductive Immunology

Volumn 73, Issue 2, 2007, Pages 166-171

  Hu, Wensheng ^a   Wang, Hanzhi ^a   Wang, Zhengping ^a   Huang, Hefeng ^a   Dong, Minyue ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Immunology; Interleukin 15; Interleukin 16; Preeclampsia; Pregnancy

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 16;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; INFLAMMATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

ADULT; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-15; INTERLEUKIN-16; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTERS;

EID: 33947180344     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2006.06.005     Document Type: Article

References (45)

1. ACOG Practice Bulletin, January 2002. Diagnosis and management of preeclampsia and eclampsia. Obstet. Gynecol. 99 (33), 159-167.
2. Agarwal R., Loganath A., Roy A.C., Wong Y.C., and Ng S.C. Expression profiles of interleukin-15 in early and late gestational human placenta and in pre-eclamptic placenta. Mol. Hum. Reprod. 7 (2001) 97-101
3. Barden A., Graham D., Beilin L.J., Ritchie J., Baker R., Walters B.N., and Michael C.A. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin. Sci. (Lond.) 92 (1997) 37-44
4. Becknell B., and Caligiuri M.A. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv. Immunol. 86 (2005) 209-239
5. Berge L.N., Ostensen M., and Revhaug A. Phagocytic cell activity in pre-eclampsia. Acta Obstet. Gynecol. Scand. 67 (1988) 499-504
6. Borzychowski A.M., Croy B.A., Chan W.L., Redman C.W., and Sargent I.L. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur. J. Immunol. 35 (2005) 3054-3063
7. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., and Caligiuri M.A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180 (1994) 1395-1403
8. Chaouat G., Zourbas S., Ostojic S., Lappree-Delage G., Dubanchet S., Ledee N., and Martal J. A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J. Reprod. Immunol. 53 (2002) 241-256
9. Del Gobbo V., Giganti M.G., Zenobi R., Villani V., and Premrov M.G. The immunosuppressive cytokines influence the fetal survival in patients with pregnancy-induced hypertension. Am. J. Reprod. Immunol. 44 (2000) 214-221
10. Dong M., He J., Wang Z., Xie X., and Wang H. Placental imbalance of Th1- and Th2-type cytokines in preeclampsia. Acta Obstet. Gynecol. Scand. 84 (2005) 788-793
11. Dong M., Wang Z., and He J. Serum T helper 1- and 2-type cytokines in preeclampsia. Int. J. Gynaecol. Obstet. 89 (2005) 288-290
12. Dudley D.J., Hunter C., Mitchell M.D., Varner M.W., and Gately M. Elevations of serum interleukin-12 concentrations in women with severe pre-eclampsia and HELLP syndrome. J. Reprod. Immunol. 31 (1996) 97-107
13. Fortunato S.J., Menon R., and Lombardi S.J. IL-15, a novel cytokine produced by human fetal membranes, is elevated in preterm labor. Am. J. Reprod. Immunol. 39 (1998) 16-23
14. Greer I.A., Haddad N.G., Dawes J., Johnstone F.D., and Calder A.A. Neutrophil activation in pregnancy-induced hypertension. Br. J. Obstet. Gynaecol. 96 (1989) 978-982
15. Haeger M., Unander M., Norder-Hansson B., Tylman M., and Bengtsson A. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet. Gynecol. 79 (1992) 19-26
16. Hamai Y., Fujii T., Yamashita T., Nishina H., Kozuma S., Mikami Y., and Taketani Y. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am. J. Reprod. Immunol. 38 (1997) 89-93
17. Huang X., Huang H., Dong M., Yao Q., and Wang H. Serum and placental interleukin-18 are elevated in preeclampsia. J. Reprod. Immunol. 65 (2005) 77-87
18. Jang G.C., Kim H.Y., Ahn S.Y., and Kim D.S. Raised serum interleukin 15 levels in Kawasaki disease. Ann. Rheum. Dis. 62 (2003) 264-266
19. Jonsson Y., Ekerfelt C., Berg G., Nieminen K., Sharma S., Ernerudh J., and Matthiesen L. Systemic Th1/Th2 cytokine responses to paternal and vaccination antigens in preeclampsia: no differences compared with normal pregnancy. Am J. Reprod. Immunol. 51 (2004) 302-310
20. Jonsson Y., Ruber M., Matthiesen L., Berg G., Nieminen K., Sharma S., Ernerudh J., and Ekerfelt C. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J. Reprod. Immunol. 70 (2006) 83-91
21. Karaki M., Dobashi H., Kobayashi R., Tokuda M., Ishida T., and Mori N. Expression of interleukin-16 in allergic rhinitis. Int. Arch. Allergy Immunol. 138 (2005) 67-72
22. Laskarin G., Strbo N., Bogovic Crncic T., Juretic K., Ledee Bataille N., Chaouat G., and Rukavina D. Physiological role of IL-15 and IL-18 at the maternal-fetal interface. Chem. Immunol. Allergy 89 (2005) 10-25
23. Liew F.Y., and McInnes I.B. Role of interleukin 15 and interleukin 18 in inflammatory response. Ann. Rheum. Dis. 61 Suppl. 2:ii (2002) 100-102
24. Lim K.H., Rice G.E., de Groot C.J., and Taylor R.N. Plasma type II phospholipase A2 levels are elevated in severe preeclampsia. Am. J. Obstet. Gynecol. 172 (1995) 998-1002
25. Lodolce J., Burkett P., Koka R., Boone D., Chien M., Chan F., Madonia M., Chai S., and Ma A. Interleukin-15 and the regulation of lymphoid homeostasis. Mol. Immunol. 39 (2002) 537-544
26. Lopez-Jaramillo P., Casas J.P., and Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz. J. Med. Biol. Res. 34 (2001) 1227-1235
27. Lynch E.A., Heijens C.A., Horst N.F., Center D.M., and Cruikshank W.W. Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5. J. Immunol. 171 (2003) 4965-4968
28. Lynch E.L., Little F.F., Wilson K.C., Center D.M., and Cruikshank W.W. Immunomodulatory cytokines in asthmatic inflammation. Cytokine Growth Factor Rev. 14 (2003) 489-502
29. Mathy N.L., Scheuer W., Lanzendorfer M., Honold K., Ambrosius D., Norley S., and Kurth R. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology 100 (2000) 63-69
30. Ohkuchi A., Minakami H., Aoya T., Haga T., Kimura H., Suzuki M., and Sato I. Expansion of the fraction of Th1 cells in women with preeclampsia: inverse correlation between the percentage of Th1 cells and the plasma level of PAI-2. Am J. Reprod. Immunol. 46 (2001) 252-259
31. Oian P., Lande K., Kjeldsen S.E., Gjesdal K., Aakesson I., Eide I., and Maltau J.M. Enhanced platelet release reaction related to arterial plasma adrenaline and blood pressure in pre-eclampsia. Br. J. Obstet. Gynaecol. 93 (1986) 548-553
32. Ostojic S., Dubanchet S., Chaouat G., Abdelkarim M., Truyens C., and Capron F. Demonstration of the presence of IL-16, IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy. Am. J. Reprod. Immunol. 49 (2003) 101-112
33. Perry Jr. K.G., and Martin Jr. J.N. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin. Obstet. Gynecol. 35 (1992) 338-350
34. Pinsonneault S., El Bassam S., Mazer B., Cruikshank W.W., and Laberge S. IL-16 inhibits IL-5 production by antigen-stimulated T cells in atopic subjects. J. Allergy Clin. Immunol. 107 (2001) 477-482
35. Redman C.W., Sacks G.P., and Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 180 (1999) 499-506
36. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
37. Roberts J.M., and Gammill H.S. Preeclampsia: recent insights. Hypertension 46 (2005) 1243-1249
38. Saito S., and Sakai M. Th1/Th2 balance in preeclampsia. J. Reprod. Immunol. 59 (2003) 161-173
39. Saito S., Sakai M., Sasaki Y., Tanebe K., Tsuda H., and Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin. Exp. Immunol. 117 (1999) 550-555
40. Seegert D., Rosenstiel P., Pfahler H., Pfefferkorn P., Nikolaus S., and Schreiber S. Increased expression of IL-16 in inflammatory bowel disease. Gut 48 (2001) 326-332
41. Seegert D., and Schreiber S. Overview: interleukin-16 and its role in inflammatory bowel disease. Curr. Opin. Investig. Drugs 3 (2002) 562-564
42. van Heel D.A. Interleukin 15: its role in intestinal inflammation. Gut 55 (2006) 444-445
43. Vince G.S., Starkey P.M., Austgulen R., Kwiatkowski D., and Redman C.W. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br. J. Obstet. Gynaecol. 102 (1995) 20-25
44. Wilson K.C., Center D.M., and Cruikshank W.W. The effect of interleukin-16 and its precursor on T lymphocyte activation and growth. Growth Factors 22 (2004) 97-104
45. Zourbas S., Dubanchet S., Martal J., and Chaouat G. Localization of pro-inflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the foetomaternal interface during murine pregnancy. Clin. Exp. Immunol. 126 (2001) 519-528